“…The expression “high‐content screening (HCS)” (5) has recently been described: “High content screening can be defined as an automated imaging approach to understanding compound activities in cellular assays where, in each well of a microplate, you can measure spatial distribution of targets in cells, individual cell and organelle morphology, and complex phenotypes. It provides the flexibility to measure cell subpopulations and to combine multiple measurements per cell, while simultaneously eliminating unwanted cells and artifacts.” (6). High Content screening is also known as chemical biology, cell based screening, chemical genetics, phenotypic screening, visual screening, cytomics, and it has a major place in pharmaceutical company drug discovery (7–9).…”